These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 26357853

  • 1. Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.
    Aghssa MM, Tarafdari AM, Tehraninejad ES, Ezzati M, Bagheri M, Panahi Z, Mahdavi S, Abbasi M.
    Reprod Health; 2015 Sep 10; 12():85. PubMed ID: 26357853
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov 10; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation.
    Bruno-Gaston J, Jung J, Kumar T, Zarutskie P, Gibbons W, Devaraj S.
    Clin Biochem; 2021 Sep 10; 95():34-40. PubMed ID: 34000288
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, Anckaert E, Devroey P, Tournaye H.
    Fertil Steril; 2013 Aug 10; 100(2):438-44. PubMed ID: 23602319
    [Abstract] [Full Text] [Related]

  • 10. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F, Liu XL, Rong N, Huang XW.
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb 10; 37(1):70-73. PubMed ID: 28224431
    [Abstract] [Full Text] [Related]

  • 11. The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study.
    Tshzmachyan R, Hambartsoumian E.
    J Gynecol Obstet Hum Reprod; 2020 Feb 10; 49(2):101643. PubMed ID: 31563697
    [Abstract] [Full Text] [Related]

  • 12. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.
    Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM.
    Fertil Steril; 2013 Aug 10; 100(2):430-7. PubMed ID: 23668992
    [Abstract] [Full Text] [Related]

  • 13. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P.
    Fertil Steril; 2006 Jan 10; 85(1):112-20. PubMed ID: 16412740
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk.
    Gao R, Liao X, Huang W, Zeng R, Qin L, Bai P.
    Front Endocrinol (Lausanne); 2022 Jan 10; 13():905263. PubMed ID: 35757417
    [Abstract] [Full Text] [Related]

  • 17. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors.
    Polyzos NP, Stoop D, Blockeel C, Adriaensen P, Platteau P, Anckaert E, Smitz J, Devroey P.
    Reprod Biomed Online; 2012 May 10; 24(5):532-9. PubMed ID: 22417669
    [Abstract] [Full Text] [Related]

  • 18. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation.
    Melado Vidales L, Fernández-Nistal A, Martínez Fernández V, Verdú Merino V, Bruna Catalán I, Bajo Arenas JM.
    Minerva Ginecol; 2017 Jun 10; 69(3):225-232. PubMed ID: 27352270
    [Abstract] [Full Text] [Related]

  • 19. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA, El-Haieg DO, El-Sebaey A.
    Fertil Steril; 2008 Jun 10; 89(6):1670-6. PubMed ID: 17658520
    [Abstract] [Full Text] [Related]

  • 20. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K, Zander-Fox D.
    Aust N Z J Obstet Gynaecol; 2015 Aug 10; 55(4):384-9. PubMed ID: 26230428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.